| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
180,310,000 |
| Market
Cap: |
41.24(B) |
| Last
Volume: |
799,597 |
Avg
Vol: |
864,930 |
| 52
Week Range: |
$191.51 - $228.9 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Seagen is a biotechnology company that develops and commercializes targeted therapies to treat cancer. Co. is commercializing ADCETRIS®, or brentuximab vedotin, for the treatment of certain CD30-expressing lymphomas, PADCEV®, or enfortumab vedotin-ejfv, for the treatment of certain metastatic urothelial cancers, TIVDAK™, or tisotumab vedotin-tftv, for the treatment of certain metastatic cervical cancers, and TUKYSA®, or tucatinib, for treatment of certain metastatic HER2-positive breast cancers. Co. is also developing a pipeline of therapies for solid tumors and blood-related cancers designed to address unmet medical needs and improve treatment outcomes for patients.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
39,326 |
484,602 |
| Total Sell Value |
$0 |
$0 |
$8,245,949 |
$88,100,996 |
| Total People Sold |
0 |
0 |
7 |
8 |
| Total Sell Transactions |
0 |
0 |
18 |
70 |
| End Date |
2024-03-28 |
2023-12-26 |
2023-06-27 |
2022-06-27 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Siegall Clay B |
President and CEO |
• • – |
2013-08-19 |
4 |
A |
$0.00 |
$0 |
D/D |
55,000 |
1,124,558 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2013-08-19 |
4 |
AS |
$40.91 |
$313,084 |
D/D |
(7,653) |
1,069,558 |
|
- |
|
| Simpson Todd E |
Chief Financial Officer |
• – – |
2013-08-19 |
4 |
A |
$0.00 |
$0 |
D/D |
14,400 |
125,029 |
|
- |
|
| Simpson Todd E |
Chief Financial Officer |
• – – |
2013-08-19 |
4 |
AS |
$40.91 |
$136,148 |
D/D |
(3,328) |
110,629 |
|
- |
|
| Dobmeier Eric |
Chief Operating Officer |
• – – |
2013-08-19 |
4 |
A |
$0.00 |
$0 |
D/D |
18,000 |
127,620 |
|
- |
|
| Dobmeier Eric |
Chief Operating Officer |
• – – |
2013-08-19 |
4 |
AS |
$40.91 |
$136,148 |
D/D |
(3,328) |
109,620 |
|
- |
|
| Himes Vaughn B |
EVP, Tech. Ops. & Proc. Sci. |
• – – |
2013-08-19 |
4 |
A |
$0.00 |
$0 |
D/D |
14,400 |
46,307 |
|
- |
|
| Himes Vaughn B |
EVP, Tech. Ops. & Proc. Sci. |
• – – |
2013-08-19 |
4 |
AS |
$40.91 |
$71,020 |
D/D |
(1,736) |
31,907 |
|
- |
|
| Boerner Christopher S. |
SVP, Commercial |
• – – |
2013-08-19 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
47,527 |
|
- |
|
| Boerner Christopher S. |
SVP, Commercial |
• – – |
2013-08-19 |
4 |
AS |
$40.91 |
$9,246 |
D/D |
(226) |
33,527 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2013-08-01 |
4 |
AS |
$40.03 |
$80,063 |
D/D |
(2,000) |
1,077,211 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2013-08-01 |
4 |
OE |
$10.33 |
$20,660 |
D/D |
2,000 |
1,079,211 |
|
- |
|
| Gryska David W |
Director |
– • – |
2013-07-16 |
5 |
GD |
$0.00 |
$0 |
D/D |
250 |
21,750 |
|
- |
|
| Simpson Todd E |
Chief Financial Officer |
• – – |
2013-07-12 |
4 |
AS |
$37.94 |
$1,803,174 |
D/D |
(47,527) |
113,957 |
|
- |
|
| Simpson Todd E |
Chief Financial Officer |
• – – |
2013-07-12 |
4 |
OE |
$12.00 |
$671,238 |
D/D |
47,527 |
143,123 |
|
- |
|
| Simpson Todd E |
Chief Financial Officer |
• – – |
2013-07-11 |
4 |
AS |
$36.94 |
$1,662,300 |
D/D |
(45,000) |
113,957 |
|
- |
|
| Simpson Todd E |
Chief Financial Officer |
• – – |
2013-07-11 |
4 |
OE |
$12.00 |
$540,238 |
D/D |
45,000 |
157,471 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2013-07-01 |
4 |
AS |
$32.59 |
$65,186 |
D/D |
(2,000) |
1,077,211 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2013-07-01 |
4 |
OE |
$10.33 |
$20,660 |
D/D |
2,000 |
1,079,211 |
|
- |
|
| Akkaraju Srinivas |
Director |
– • – |
2013-06-14 |
4 |
S |
$32.75 |
$163,750 |
D/D |
(5,000) |
13,905 |
|
- |
|
| Akkaraju Srinivas |
Director |
– • – |
2013-06-14 |
4 |
OE |
$8.38 |
$41,900 |
D/D |
5,000 |
18,905 |
|
- |
|
| Himes Vaughn B |
EVP, Tech. Ops. & Proc. Sci. |
• – – |
2013-06-13 |
4 |
S |
$32.11 |
$321,100 |
D/D |
(10,000) |
33,643 |
|
- |
|
| Himes Vaughn B |
EVP, Tech. Ops. & Proc. Sci. |
• – – |
2013-06-13 |
4 |
OE |
$9.23 |
$92,300 |
D/D |
10,000 |
43,643 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2013-06-03 |
4 |
AS |
$33.88 |
$67,762 |
D/D |
(2,000) |
1,077,211 |
|
- |
|
| Siegall Clay B |
President and CEO |
• • – |
2013-06-03 |
4 |
OE |
$10.33 |
$20,660 |
D/D |
2,000 |
1,079,211 |
|
- |
|
1805 Records found
|
|
Page 41 of 73 |
|
|
